Aileron Therapeutics Stock Quote ALRN - Stock Price, News, Charts, Message Board, Trades

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

1.75

Bid

1.61

Ask

2.22

Volume

70,422

1.70 Day's Range 1.88

1.61 52 Week Range 7.42

Market Cap

37.915M

Previous Close

1.76

Open

1.80

Last Trade

12510

1.75

Last Trade Time

Financial Volume

$ 126,892

VWAP

1.8019

Average Volume (3m)

78,257

Shares Outstanding

21,665,941

Dividend Yield

PE Ratio

-2.44

Earnings Per Share (EPS)

-0.73

Revenue

Net Profit

-15.73M

Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in pat... Aileron Therapeutics Inc a clinical-stage biopharmaceutical company. It is focused on developing a novel class of therapeutics for the treatment of cancer and other diseases. The company's lead product candidate, ALRN-6924 is a novel chemoprotective medicine to treat and protect healthy cells in patients with cancer that harbors p53 mutations to reduce or eliminate chemotherapy-induced side effects. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.aileronrx.com

Headquarters

Wilmington, Delaware, USA

Founded

Aileron Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker ALRN. The last closing price for Aileron Therapeutics was $1.76. Over the last year, Aileron Therapeutics shares have traded in a share price range of $ 1.61 to $ 7.42.

Aileron Therapeutics currently has 21,665,941 shares outstanding. The market capitalization of Aileron Therapeutics is $38.13 million. Aileron Therapeutics has a price to earnings ratio (PE ratio) of -2.44.

Form 4 - Statement of changes in beneficial ownership of securities

Aileron Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

Aileron Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights PR Newswire AUSTIN, Texas, Nov. 14, 2024 Announced promising safety and positive biomarker data...

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aileron Therapeutics Announces Positive Topline Data from Cohort 2 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF)

Aileron Therapeutics Announces Positive Topline Data from Cohort 2 of the Phase 1b Clinical Trial of LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) PR Newswire WALTHAM, Mass., Nov. 13, 2024...

Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma

Aileron Therapeutics and Advancium Health Network Announce an Exclusive Option Agreement for the Acquisition of ALRN-6924 for Retinoblastoma PR Newswire AUSTIN, Texas and NEW YORK, Oct. 31, 2024...

Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) at the 22nd International Colloquium on Lung and Airway Fibrosis

Aileron Therapeutics to Present Previously Announced Data from the Phase 1b Clinical Trial Evaluating Low-Dose LTI-03 in Idiopathic Pulmonary Fibrosis (IPF) at the 22nd International Colloquium...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-0.33	-15.8653846154	2.08	2.38	1.75	128009	2.08759297	CS
4	-0.86	-32.9501915709	2.61	2.96	1.75	91316	2.24485466	CS
12	-1.9	-52.0547945205	3.65	4.4	1.75	78257	3.05351844	CS
26	-1.31	-42.8104575163	3.06	4.4	1.61	79799	2.94982319	CS
52	-1.54	-46.8085106383	3.29	7.42	1.61	75906	3.64628964	CS
156	-8.832	-83.4624834625	10.582	15	1.01	224037	5.5801992	CS
260	-9.424	-84.338643279	11.174	49.4	1.01	589648	23.30546273	CS

ALRN - Frequently Asked Questions (FAQ)

What is the current Aileron Therapeutics share price?

The current share price of Aileron Therapeutics is $ 1.75

How many Aileron Therapeutics shares are in issue?

Aileron Therapeutics has 21,665,941 shares in issue

What is the market cap of Aileron Therapeutics?

The market capitalisation of Aileron Therapeutics is USD 38.13M

What is the 1 year trading range for Aileron Therapeutics share price?

Aileron Therapeutics has traded in the range of $ 1.61 to $ 7.42 during the past year

What is the PE ratio of Aileron Therapeutics?

The price to earnings ratio of Aileron Therapeutics is -2.44

What is the reporting currency for Aileron Therapeutics?

Aileron Therapeutics reports financial results in USD

What is the latest annual profit for Aileron Therapeutics?

The latest annual profit of Aileron Therapeutics is USD -15.73M

What is the registered address of Aileron Therapeutics?

The registered address for Aileron Therapeutics is 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801

What is the Aileron Therapeutics website address?

The website address for Aileron Therapeutics is www.aileronrx.com

Which industry sector does Aileron Therapeutics operate in?

Aileron Therapeutics operates in the PHARMACEUTICAL PREPARATIONS sector

Symbol	Price	Vol.
MYSZMy Size Inc	$ 4.2001 (211.12%)	120.01M
NVNINVNI Group Ltd	$ 8.26 (209.36%)	76.64M
TPICTPI Composites Inc	$ 2.45 (100.82%)	33.95M
ICGIntchains Group Ltd	$ 8.77 (88.60%)	527.61k
HSDTHelius Medical Technologies Inc	$ 0.884851 (84.34%)	120.4M
CYNCYNGN Inc	$ 0.4603 (-71.41%)	27.5M
MTEMMolecular Templates Inc	$ 0.1502 (-57.09%)	8.63M
PRFXPainReform Ltd	$ 5.15 (-53.85%)	2.84M
GALTGalectin Therapeutics Inc	$ 1.03 (-48.50%)	8.58M
BCABBioAtla Inc	$ 0.6923 (-41.82%)	5.96M
EDBLEdible Garden AG Inc	$ 0.24 (65.06%)	354.33M
NVDANVIDIA Corporation	$ 134.70 (3.08%)	310.19M
APTOAptose Biosciences Inc	$ 0.28 (64.51%)	306.25M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.606999 (6.49%)	293.22M
PLTRPalantir Technologies Inc	$ 80.55 (8.54%)	281.23M

Symbol

Price

Vol.